Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.

Article  PubMed  Google Scholar 

Coleman HG, Xie SH, Lagergren J. The epidemiology of esophageal adenocarcinoma. Gastroenterology. 2018;154(2):390–405.

Article  PubMed  Google Scholar 

Arnold M, Soerjomataram I, Ferlay J, Forman D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2015;64(3):381–7.

Article  PubMed  Google Scholar 

Lin Y, Totsuka Y, He Y, et al. Epidemiology of esophageal cancer in Japan and China. J Epidemiol. 2013;23(4):233–42.

Article  PubMed  Google Scholar 

Yan HJ, Mao WJ, Yu RX, et al. Preoperative clinical characteristics predict recurrent laryngeal nerve lymph node metastasis and overall survival in esophageal squamous cell carcinoma: a retrospective study with external validation. Front Oncol. 2022;12:859952.

Article  PubMed  PubMed Central  Google Scholar 

Zeng H, Chen W, Zheng R, et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health. 2018;6(5):e555–67.

Article  PubMed  Google Scholar 

Faragher AJ, Fry AM. Nek2A kinase stimulates centrosome disjunction and is required for formation of bipolar mitotic spindles. Mol Biol Cell. 2003;14(7):2876–89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee J, Gollahon L. Nek2-targeted ASO or siRNA pretreatment enhances anticancer drug sensitivity in triplenegative breast cancer cells. Int J Oncol. 2013;42(3):839–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Peres A, Kazuo Issayama L, Betim Pavan IC, et al. Checking NEKs: overcoming a Bottleneck in Human Diseases. Molecules. 2020;25:8.

Google Scholar 

Wang S, Li W, Liu N, et al. Nek2A contributes to tumorigenic growth and possibly functions as potential therapeutic target for human breast cancer. J Cell Biochem. 2012;113(6):1904–14.

Article  CAS  PubMed  Google Scholar 

Cappello P, Blaser H, Gorrini C, et al. Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells. Oncogene. 2014;33(18):2375–84.

Article  CAS  PubMed  Google Scholar 

Liu S, Tian W, Li B. Integrative Bioinformatics Analysis identifies NEK2 as a potential biomarker in Head and Neck squamous cell carcinoma. J Comput Biol. 2020;27(1):100–8.

Article  CAS  PubMed  Google Scholar 

Neal CP, Fry AM, Moreman C, et al. Overexpression of the Nek2 kinase in colorectal cancer correlates with beta-catenin relocalization and shortened cancer-specific survival. J Surg Oncol. 2014;110(7):828–38.

Article  CAS  PubMed  Google Scholar 

Xing Z, Zhang M, Wang X, et al. Silencing of Nek2 suppresses the proliferation, migration and invasion and induces apoptosis of breast cancer cells by regulating ERK/MAPK signaling. J Mol Histol. 2021;52(4):809–21.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Wang W, Wang Y, et al. NEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial–mesenchymal transition. Oncol Rep. 2018;39(3):1023–33.

CAS  PubMed  PubMed Central  Google Scholar 

Wang C, Huang Y, Ma X, Wang B, Zhang X. Overexpression of NEK2 is correlated with poor prognosis in human clear cell renal cell carcinoma. Int J Immunopathol Pharmacol. 2021;35:20587384211065893.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu X, Gao Y, Lu Y, Zhang J, Li L, Yin F. Upregulation of NEK2 is associated with drug resistance in ovarian cancer. Oncol Rep. 2014;31(2):745–54.

Article  PubMed  Google Scholar 

Hayward DG, Clarke RB, Faragher AJ, Pillai MR, Hagan IM, Fry AM. The centrosomal kinase Nek2 displays elevated levels of protein expression in human breast cancer. Cancer Res. 2004;64(20):7370–6.

Article  CAS  PubMed  Google Scholar 

Chen C, Peng S, Li P, Ma L, Gan X. High expression of NEK2 promotes lung cancer progression and drug resistance and is regulated by mutant EGFR. Mol Cell Biochem. 2020;475(1–2):15–25.

Article  CAS  PubMed  Google Scholar 

Chu CY, Wang R, Liu XL. Roles of Wnt/beta-catenin signaling pathway related microRNAs in esophageal cancer. World J Clin Cases. 2022;10(9):2678–86.

Article  PubMed  PubMed Central  Google Scholar 

Ng LF, Kaur P, Bunnag N, et al. WNT signaling in disease. Cells. 2019;8(8):826.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bai F, Zuo C, Ouyang Y, Xiao K, He Z, Yang Z. Circular RNA 0001666 inhibits colorectal cancer cell proliferation, invasion and stemness by inactivating the Wnt/beta-catenin signaling pathway and targeting microRNA-1229. Oncol Lett. 2022;23(5):153.

CAS  PubMed  PubMed Central  Google Scholar 

Yang L, Chen Y, Cui T, et al. Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/beta-catenin signaling pathway in human lung cancer. Carcinogenesis. 2012;33(10):1863–70.

Article  CAS  PubMed  Google Scholar 

Zhang LZ, Huang LY, Huang AL, Liu JX, Yang F. CRIP1 promotes cell migration, invasion and epithelial–mesenchymal transition of cervical cancer by activating the Wnt/betacatenin signaling pathway. Life Sci. 2018;207:420–7.

Article  CAS  PubMed  Google Scholar 

Zong D, Yin L, Zhong Q, et al. ZNF488 enhances the invasion and tumorigenesis in nasopharyngeal carcinoma via the wnt signaling pathway involving epithelial mesenchymal transition. Cancer Res Treat. 2016;48(1):334–44.

Article  CAS  PubMed  Google Scholar 

Visweswaran M, Keane KN, Arfuso F, Dilley RJ, Newsholme P, Dharmarajan A. The influence of breast tumour-derived factors and wnt antagonism on the Transformation of adipose-derived mesenchymal stem cells into tumour-associated fibroblasts. Cancer Microenviron. 2018;11(1):71–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nawshad A, Lagamba D, Polad A, Hay ED. Transforming growth factor-beta signaling during epithelial–mesenchymal transformation: implications for embryogenesis and tumor metastasis. Cells Tissues Organs. 2005;179(1–2):11–23.

Article  CAS  PubMed  Google Scholar 

Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–8.

Article  CAS  PubMed  Google Scholar 

Williams ED, Gao D, Redfern A, Thompson EW. Controversies around epithelial–mesenchymal plasticity in cancer metastasis. Nat Rev Cancer. 2019;19(12):716–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jin X, Liu L, Wu J, et al. A multi-omics study delineates new molecular features and therapeutic targets for esophageal squamous cell carcinoma. Clin Transl Med. 2021;11(9):e538.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Salem ME, Puccini A, Xiu J, et al. Comparative molecular analyses of esophageal squamous cell carcinoma, esophageal adenocarcinoma, and gastric adenocarcinoma. Oncologist. 2018;23(11):1319–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yamana H. [Molecular biology for esophageal squamous cell carcinoma]. Nihon Rinsho. 2011;69(Suppl 6):51–6.

PubMed  Google Scholar 

Shreeram S, Hee WK, Bulavin DV. Cdc25A serine 123 phosphorylation couples centrosome duplication with DNA replication and regulates tumorigenesis. Mol Cell Biol. 2008;28(24):7442–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ha Kim Y, Yeol Choi J, Jeong Y, Wolgemuth DJ, Rhee K. Nek2 localizes to multiple sites in mitotic cells, suggesting its involvement in multiple cellular functions during the cell cycle. Biochem Biophys Res Commun. 2002;290(2):730–6.

Article  PubMed  Google Scholar 

Li Y, Chen L, Feng L, et al. NEK2 promotes proliferation, migration and tumor growth of gastric cancer cells via regulating KDM5B/H3K4me3. Am J Cancer Res. 2019;9(11):2364–78.

CAS  PubMed  PubMed Central  Google Scholar 

Fang Y, Kong Y, Xi J, et al. Preclinical activity of MBM-5 in gastrointestinal cancer by inhibiting NEK2 kinase activity. Oncotarget. 2016;7(48):79327–41.

Article  PubMed  PubMed Central  Google Scholar 

Feng X, Guo J, An G, et al. Genetic aberrations and interaction of NEK2 and TP53 accelerate aggressiveness of multiple myeloma. Adv Sci (Weinh). 2022;9(9):e2104491.

Article  PubMed  Google Scholar